Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

420.65INR
3:47pm IST
Change (% chg)

Rs-6.15 (-1.44%)
Prev Close
Rs426.80
Open
Rs426.70
Day's High
Rs427.55
Day's Low
Rs419.15
Volume
3,367,950
Avg. Vol
8,103,441
52-wk High
Rs668.25
52-wk Low
Rs344.55

Latest Key Developments (Source: Significant Developments)

India's Sun Pharma Raises Stake In PJSC Biosintez To 100%
Monday, 9 Sep 2019 

Sept 9 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS INCREASED STAKE IN PJSC BIOSINTEZ OF RUSSIA TO 100% FROM 96.96% BY PURCHASE OF SHARES.  Full Article

Sun Pharmaceutical Industries Enters Licensing Agreement With China Medical System Holdings
Friday, 16 Aug 2019 

Aug 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMA AND CHINA MEDICAL SYSTEM HOLDINGS ENTER INTO LICENSING AGREEMENT FOR GENERIC PRODUCTS IN MAINLAND CHINA.TERM OF AGREEMENT TO BE 20 YEARS FROM FIRST COMMERCIAL SALE OF PRODUCTS IN MAINLAND CHINA, MAYBE EXTENDED BY 3 YRS.  Full Article

Sun Pharmaceutical Industries Partners CSIR-IICT
Wednesday, 14 Aug 2019 

Aug 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::ANNOUNCES LICENSING AGREEMENT WITH CSIR-IICT.CSIR-IICT TO GET UPFRONT PLUS MILESTONE PAYMENTS AND ROYALTIES ON NET SALES.GETS EXCLUSIVE GLOBAL LICENSE FOR CSIR-IICT’S PATENTS RELATED TO CERTAIN COMPOUNDS.  Full Article

China Medical System Says Unit Signs License Agreement With Unit Of Sun Pharmaceutical Industries
Thursday, 27 Jun 2019 

June 27 (Reuters) - China Medical System Holdings Ltd <0867.HK>::UNIT SIGNS A LICENSE AGREEMENT OF CYCLOSPORINE A FOR TREATMENT OF DRY EYE DISEASE WITH UNIT OF SUN PHARMACEUTICAL INDUSTRIES.  Full Article

China Medical System Signs License Agreement With Unit Of Sun Pharmaceutical Industries
Thursday, 27 Jun 2019 

June 27 (Reuters) - China Medical System Holdings Ltd <0867.HK>::SIGNED A LICENSE AGREEMENT WITH A UNIT OF SUN PHARMACEUTICAL INDUSTRIES LTD.LICENSE AGREEMENT FOR PRODUCT TILDRAKIZUMAB FOR TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS.  Full Article

Sun Pharmaceutical Industries Says U.S. FDA Conducted Pre-Approval Inspection Of Co's Baska Facility
Monday, 25 Mar 2019 

March 25 (Reuters) - Sun Pharmaceutical Industries Ltd ::U.S. FDA CONDUCTED PRE-APPROVAL INSPECTION OF CO'S BASKA FACILITY (GUJARAT) FROM JANUARY 28 TO FEBRUARY 5, 2019.U.S. FDA ISSUED FORM 483, WITH ONE OBSERVATIO‍​N.  Full Article

Sun Pharmaceutical Industries Exec Says Received Query From SEBI For 2004 FCCBs Issuance, Deals With Aditya Medisales
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Sun Pharmaceutical Industries Ltd MD Dilip Shanghvi::SUN PHARMACEUTICAL INDUSTRIES EXEC SAYS DON'T HAVE INFO ON WHISTLEBLOWER COMPLAINTS.SUN PHARMACEUTICAL INDUSTRIES EXEC SAYS RECEIVED QUERY FROM SEBI FOR 2004 FCCBS ISSUANCE, DEALS WITH ADITYA MEDISALES.SUN PHARMACEUTICAL INDUSTRIES EXEC SAYS DECIDED NOT TO LAUNCH ELEPSIA IN THE U.S..  Full Article

India's Sun Pharmaceutical Industries Dec-Qtr Consol Net Profit Surges 286.2 Pct
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Sun Pharmaceutical Industries Ltd ::DEC QUARTER CONSOL NET PROFIT 12.42 BILLION RUPEES VERSUS PROFIT OF 3.22 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 9.86 BILLION RUPEES.DEC QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 77.40 BILLION RUPEES VERSUS 66.53 BILLION RUPEES LAST YEAR.  Full Article

Sun Pharma Makes Unit Distributor Of Domestic Formulations Business
Tuesday, 22 Jan 2019 

Jan 22 (Reuters) - Sun Pharmaceutical Industries Ltd ::DISTRIBUTION RELATED TO INDIA DOMESTIC FORMULATIONS BUSINESS TO BE TRANSITIONED FROM ADITYA MEDISALES TO A UNIT OF CO.TRANSITION WILL BE MADE EFFECTIVE BY Q1FY20.CONFIRMS THAT NEITHER ANY LOANS NOR GUARANTEES HAVE BEEN GIVEN TO SURAKSHA REALTY.DOES NOT HAVE ANY FINANCIAL TRANSACTIONS WITH SURAKSHA REALTY.INITIATED STEPS TO INDUCT S R B C & CO LLP AS AUDITORS OF SUBSIDIARIES THAT ARE CURRENTLY AUDITED BY VALIA & TIMBADIA..SUPPLY CONTRACT PARTIES AGREED THAT ATLAS WILL ASSIGN ITS RIGHTS, OBLIGATIONS FROM CONTRACT, TO CO'S UNIT.ASSIGNMENT WILL ENSURE THAT THE LOANS & ADVANCES GIVEN TO ATLAS WILL BE SETTLED.  Full Article

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall Of Vecuronium Bromide For Injection
Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMACEUTICAL INDUSTRIES, INC. ISSUES VOLUNTARY NATIONWIDE RECALL OF VECURONIUM BROMIDE FOR INJECTION DUE TO THE PRESENCE OF PARTICULATE MATTER IDENTIFIED AS GLASS.SUN PHARMACEUTICAL-RECALLING THREE LOTS OF VECURONIUM BROMIDE FOR INJECTION 10 MG, ONE LOT OF VECURONIUM BROMIDE FOR INJECTION 20 MG TO HOSPITAL LEVEL.SUN PHARMACEUTICAL INDUSTRIES - TO DATE, SPII HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS RELATED TO THIS RECALL.  Full Article